High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
about
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.Click chemistry in complex mixtures: bioorthogonal bioconjugationThe use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.Modular and orthogonal synthesis of hybrid polymers and networks(E,E)-1,5-Cyclooctadiene: a small and fast click-chemistry multitalentInitial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma.Imaging the DNA damage response with PET and SPECTSynthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation.Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.Biomedical applications of tetrazine cycloadditions.Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ₃ targeted PET tracer based on a cyclic RGD peptideNoninvasive imaging of immune responses.Conformationally Strained trans-Cyclooctene with Improved Stability and Excellent Reactivity in Tetrazine Ligation.Nanoparticle-mediated measurement of target-drug binding in cancer cellsImaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agentsReactive polymer enables efficient in vivo bioorthogonal chemistry.Dual-Modality Optical/PET Imaging of PARP1 in GlioblastomaNon-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone miceEfficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta CellsClick Chemistry and Radiochemistry: The First 10 Yearstrans-Cyclooctene--a stable, voracious dienophile for bioorthogonal labeling.Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis.Expanding room for tetrazine ligations in the in vivo chemistry toolbox.New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.The inverse electron demand Diels-Alder click reaction in radiochemistry.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.Inverse Electron-Demand Diels-Alder Bioorthogonal Reactions.Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor.Molecular Imaging of PARP.Fluorine-18 labelled building blocks for PET tracer synthesis.18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography.Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation.Copper-Free Click for PET: Rapid 1,3-Dipolar Cycloadditions with a Fluorine-18 Cyclooctyne.Design and synthesis of highly reactive dienophiles for the tetrazine-trans-cyclooctene ligation.Meter-long multiblock copolymer microfibers via interfacial bioorthogonal polymerization.Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine.Interfacial Bioorthogonal Cross-Linking.
P2860
Q26822871-245DBA93-D561-41B3-9E86-70ACD0D7C2D1Q26828895-013085C7-784F-4562-A030-CBA3848D36FAQ27300759-457C7896-5210-42E5-94C6-A74E6549601FQ28087551-E94BD599-8FD6-4FDD-B87B-60771CFF5766Q29545038-AE1089E4-3CD2-4B73-B9E4-0D5D31993CA5Q30252194-7E6CA96A-D22B-4D87-B2E0-4A1508E1E846Q33581909-74F0EEC5-8CE9-4744-9227-E521079CC380Q33607384-BC5CA355-4786-43A1-B679-802AEB969A9CQ33637137-3332597B-2F1A-45E4-939F-189C97B95489Q33929151-D59325FF-4874-4621-93C8-6F9A6F2D648BQ35162177-54B5594E-FE4E-4752-A3C5-DFDAD9A7AC58Q35194732-D2EE3AFB-D68E-483F-93B2-09E82CEA6FADQ35591595-1A00FBDE-6282-4913-8D65-D22AA23DF6ABQ35616275-62920B66-9076-4011-BA7D-4F81C8EC738EQ35768570-E56DBF21-B0F5-4F57-BD93-B1F0F9E3AA6FQ35813733-2C11822D-A939-4480-BE23-D7461BF5BC81Q35882189-9800023E-C2D1-4F95-AB92-6BA108345DA1Q35882501-831EB83A-0C87-40E2-8C99-87E897668FE7Q36172457-AEE2BC0E-9C07-43DC-B356-53C81DD0F568Q36827491-B6050FF6-0A25-4F4F-B3B0-AFDC6DEC0787Q36867835-5670427C-C977-4A5C-AB8E-6FAEE01D6AD9Q37134464-1E0C35B6-FEF9-400A-8F03-4B0749965B72Q37540109-DE6A7E2F-3F56-4E4A-8F6C-DC32DE847CC0Q37586171-40E31EC0-09C3-4F26-9FA1-387DF8A31235Q37724107-8CBB2D37-FAD8-4477-8BD6-944E09175696Q37728469-03978055-A2FF-479A-B151-9DA7148A8B09Q38040666-8AEBBDAF-65FB-4A19-844B-34430D80A14AQ38172061-28BE2913-8BAB-4726-AB53-F4D70A5E02B3Q38206206-AB9035C4-F8A4-44BD-9ABD-D80E5031FD97Q38826711-7C4EE101-9F22-4CA8-A632-783E6B740D26Q38938436-114CA0B5-8A1F-4FF4-BCE1-CF38E0409CDEQ39284725-BB748F28-65CC-4AF8-A541-6F4ABFD1DF9FQ39369099-29BCAE72-30E1-499F-8877-866E98563E6AQ39432870-21E01C6B-C4DA-49A4-9845-E2035AEA448EQ39467640-AACFE111-24DF-4B84-8841-803E57AA54A5Q39514580-18F2D467-85AC-49C7-8AC6-E4BFE032E29BQ39589976-65FE6C17-1719-4F0E-B73E-E07BE9076494Q40405903-D9568182-E7B3-4918-9D20-83358F0C4670Q42044376-392F4FF7-CF43-420B-A796-83EEE3CA8521Q42095958-23A1D9C4-1523-4355-B1F9-BA77D2300B8A
P2860
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@en
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@nl
type
label
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@en
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@nl
prefLabel
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@en
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@nl
P2093
P2860
P356
P1433
P1476
High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors
@en
P2093
Anna Turetsky
Edmund J Keliher
Scott A Hilderbrand
P2860
P304
P356
10.1002/CMDC.201000426
P577
2011-01-04T00:00:00Z